期刊文献+

心肌淀粉样变诊断进展 被引量:4

暂未订购
导出
摘要 心肌淀粉样变(Cardiacamyloidosis,CA)是系统性淀粉样变性最常见的临床表现之一,临床上常以合并症或者单独发病的形式被发现。淀粉样变性可累及许多器官并最终导致器官衰竭,累及心脏时预后极差,因此有淀粉样变性疾病的患者均应排除CA。CA系淀粉样蛋白质物质沉积在心肌组织内,改变细胞代谢、钙转运、受体调节和细胞水肿等所致的一种限制性心肌病。CA较为少见,且临床表现多样化及缺乏特异性,易将其漏诊或误诊为肥厚型心肌病或其他病因的限制性心肌病。
出处 《心脑血管病防治》 2013年第6期475-477,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献28

  • 1Murtagh B, Hammill SC, Gertz MA" et al. Electrocardiographic Findings in Primary Systemic Amyloidosis and Biopsy - Proven Cardiac Involvement[J]. AmJ Cardiol,2005,95(4) :535 - 537.
  • 2Cheng Z, Zhu K, Tian Z, et al. The findings of electrocardiography in pa?tients with cardiac amyloidosisJ J}. Ann Noninvasive Electrocardiol,2013, 18(2): 157 - 162.
  • 3Murtagh B, Hammill SC, Gertz MA, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement[J] . AmJ Cardiol,2005,95 (4) :535 - 537.
  • 4RahmanJE, Helou EF, Gelzer BR, et al. Noninvasive diagnosis of biop?sy-proven cardiac amyloidosis[J].J Am Coil Cardiol,2004,43(3):410- 415.
  • 5程中伟,田庄,康琳,陈太波,方理刚,程康安,曾勇,方全.心脏淀粉样变患者的心电图和心脏超声特点[J].中华心血管病杂志,2010,38(7):606-609. 被引量:25
  • 6Hongo M, Yamamo to H, Kohda T. Comparison of elect rocardiograph findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic[J] ' AmJ Cardiol,2000,85(7) :849 - 853.
  • 7潘慧超,张丽华.心肌淀粉样变性的诊断与治疗[J].河北医学,2010,16(8):1007-1009. 被引量:13
  • 8张丽,吕清,谢明星,王新房,杨亚利,贺林,卢晓芳,王静,项飞翔,陈明.超声心动图对心肌淀粉样变的诊断价值[J].中华超声影像学杂志,2009,18(1):11-13. 被引量:8
  • 9高瑛子,高传玉,刘煜昊,李牧蔚,王现青,牛振民.23例心肌淀粉样变性临床分析[J].中华实用诊断与治疗杂志,2009,23(3):297-298. 被引量:4
  • 10Falk RH, PlehnJF, Deering T, et al. Sensitivity and specificity of the e?chocar-diographic features of cardiac amyloidosis[J]. AmJ Cardiol, 1987 , 59 (5) :418 - 422.

二级参考文献76

  • 1舒砚文,廖玉华,王祥,李裕舒,冯义柏,郑丽端,杨秀萍.淀粉样变心肌病报告及文献复习[J].临床心血管病杂志,2005,21(7):447-448. 被引量:4
  • 2林静娜,孙静平,杨兴生.淀粉样变心肌病[J].中国医刊,2006,41(2):49-51. 被引量:8
  • 3冷芸,李利红.原发性系统性淀粉样变性1例[J].临床血液学杂志,2007,20(3):175-176. 被引量:6
  • 4孟磊,丁文惠,史力斌,龚艳君,刘兆平.免疫球蛋白轻链型淀粉样变性病心脏受累的临床特征及预后[J].中华心血管病杂志,2007,35(4):340-343. 被引量:10
  • 5Wood MJ, Picard MH. Utility of echocardiography in the evaluation of individuals with cardiomyopathy. Heart, 2004,917:707-712.
  • 6Bellavia D, Abraham TP, Pellikka PA, et al. Dectection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography.J Am Soc Echocardiogr, 2007, 20:1194- 1202.
  • 7Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol, 2008,51 : 1022-1030.
  • 8Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol,1985,6:737-743.
  • 9马文珠,张寄南.心肌疾病.第2版.南京:江苏科学技术出版社,2001:238-241.
  • 10Tel C, Dujardin KS, Hodge DO, et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol, 1996,28 : 658-664.

共引文献76

同被引文献23

  • 1AUSTIN B, DUFFY B, TAN C,et al. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortalityin endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol, 2009, 103(10): 1429-1433.
  • 2RAHMAN J, HELOU E, GELZER-BELL R,et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coil Cardiol, 2004, 43(3): 410-415.
  • 3HONGO M, YAMAMOTO H, KOHDA T, et al. Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings. The American journal of cardiology, 2000, 85(7): 849-853.
  • 4SEWARD J, CASACLANG-VERZOSA G. Infiltrative cardiovascular diseases: cardiomyopathies that look Mike. J Am Coil Cardiol, 2010, 55(17): 1769-1779.
  • 5MURTAGH B, HAMMILL S C, GERTZ M A, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. The American journal of cardiology, 2005, 95 (4): 535-537.
  • 6Rahman JE, Helou EF, Gelzer-Bell R, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis[J]. J Am Coll Cardiol, 2004, 43(3): 410-415.
  • 7Murtagh B, Hammill SC, Gertz MA, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement[J]. Am J Cardiol, 2005, 95(4): 535-537.
  • 8Klein AL, Hatle LK, assessment of right amyloidosis[J]. J Am Burstow D J, et al. Comprehensive Doppler ventricular diastolic function in cardiac Coll Cardiol, 1990, 15(1): 99-108. DOI:10.1016/0735-1097(90)90183-P.
  • 9Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review [J]. Arch Intern Med, 2006, 166(17): 1505- 1813.
  • 10Kristen AV, Dengler TJ, Hegenbart U, et al. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death [J]. Heart Rhythm, 2008, 5(2): 235-240.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部